These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8829180)

  • 1. Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation.
    Hadac EM; Ghanekar DV; Holicky EL; Pinon DI; Dougherty RW; Miller LJ
    Pancreas; 1996 Aug; 13(2):130-9. PubMed ID: 8829180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells. Similarities and differences relative to native pancreatic acinar cell receptors.
    Ozcelebi F; Rao RV; Holicky E; Madden BJ; McCormick DJ; Miller LJ
    J Biol Chem; 1996 Feb; 271(7):3750-5. PubMed ID: 8631990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling.
    Ji Z; Hadac EM; Henne RM; Patel SA; Lybrand TP; Miller LJ
    J Biol Chem; 1997 Sep; 272(39):24393-401. PubMed ID: 9305898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor.
    Ghanekar D; Hadac EM; Holicky EL; Miller LJ
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1206-12. PubMed ID: 9316827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches.
    Miller LJ
    Yale J Biol Med; 1992; 65(5):441-8; discussion 465-9. PubMed ID: 1340061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of cholecystokinin receptor phosphorylation in agonist-stimulated desensitization of pancreatic acinar cells and receptor-bearing Chinese hamster ovary cholecystokinin receptor cells.
    Rao RV; Roettger BF; Hadac EM; Miller LJ
    Mol Pharmacol; 1997 Feb; 51(2):185-92. PubMed ID: 9203622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphopeptide mapping of cholecystokinin receptors on agonist-stimulated native pancreatic acinar cells.
    Ozcelebi F; Miller LJ
    J Biol Chem; 1995 Feb; 270(7):3435-41. PubMed ID: 7531708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas.
    Le Meuth V; Philouze-Rome V; Le Huerou-Luron I; Formal M; Vaysse N; Gespach C; Guilloteau P; Fourmy D
    Endocrinology; 1993 Sep; 133(3):1182-91. PubMed ID: 8365360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
    Fourmy D; Lopez P; Poirot S; Jimenez J; Dufresne M; Moroder L; Powers SP; Vaysse N
    Eur J Biochem; 1989 Nov; 185(2):397-403. PubMed ID: 2583188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of carbohydrate moieties of cholecystokinin receptors in cholecystokinin octapeptide binding: alteration of binding data by specific lectins.
    Santer R; Leung YK; Alliet P; Lebenthal E; Lee PC
    Biochim Biophys Acta; 1990 Jan; 1051(1):78-83. PubMed ID: 2297543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell.
    Roettger BF; Rentsch RU; Hadac EM; Hellen EH; Burghardt TP; Miller LJ
    J Cell Biol; 1995 Aug; 130(3):579-90. PubMed ID: 7622559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct identification of a second distinct site of contact between cholecystokinin and its receptor.
    Hadac EM; Pinon DI; Ji Z; Holicky EL; Henne RM; Lybrand TP; Miller LJ
    J Biol Chem; 1998 May; 273(21):12988-93. PubMed ID: 9582333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification.
    Gimpl G; Anders J; Thiele C; Fahrenholz F
    Eur J Biochem; 1996 May; 237(3):768-77. PubMed ID: 8647124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor.
    Pearson RK; Miller LJ; Hadac EM; Powers SP
    J Biol Chem; 1987 Oct; 262(28):13850-6. PubMed ID: 3654639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence microscopic studies and flow cytometric measurements of lectin and hormone binding to isolated rat pancreatic acinar cells.
    Jonas L; Walzel H; Fulda G; Schulz U
    Acta Histochem; 1993 Dec; 95(2):169-76. PubMed ID: 8135089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
    Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
    Klueppelberg UG; Molero X; Barrett RW; Miller LJ
    Mol Pharmacol; 1990 Aug; 38(2):159-63. PubMed ID: 2200953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy.
    Harikumar KG; Clain J; Pinon DI; Dong M; Miller LJ
    J Biol Chem; 2005 Jan; 280(2):1044-50. PubMed ID: 15520004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist.
    Roettger BF; Pinon DI; Burghardt TP; Miller LJ
    Am J Physiol; 1999 Mar; 276(3):C539-47. PubMed ID: 10069980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.